Prelims 2025 · Q48
Easyप्रायः समाचारों में चर्चित, एकक्लोनी प्रतिरक्षियों (मोनोक्लोनल ऐंटिबॉडी) के संदर्भ में, निम्नलिखित कथनों पर विचार कीजिए :
- I.वे मानव-निर्मित प्रोटीन हैं।
- II.वे विशिष्ट प्रतिजनों (एंटीजेन) से बंधन बनाने की अपनी क्षमता के कारण प्रतिरक्षात्मक प्रकार्य को उद्दीपित करते हैं।
- III.वे निपा विषाणु के संक्रमण जैसे विषाणु संक्रमणों के उपचार में प्रयुक्त होते हैं।
उपर्युक्त कथनों में कौन-कौन से सही हैं?
Read this question in English
With reference to monoclonal antibodies, often mentioned in news, consider the following statements:
I. They are man-made proteins.
II. They stimulate immunological function due to their ability to bind to specific antigens.
III. They are used in treating viral infections like that of Nipah virus.
Which of the statements given above are correct?
(a) I and II only · (b) II and III only · (c) I and III only · (d) I, II and III
उत्तर और व्याख्या · explanation in English
Answer: (d) I, II और III
All three statements are correct. Monoclonal antibodies are identical antibody proteins made in a laboratory, each locking on to one specific antigen, and one of them (m102.4) was kept ready in India to treat Nipah virus patients.
- ✓ I They are antibodies, which are proteins, produced in the laboratory (for example from hybridoma cells), not by the patient's own body.
- ✓ II Each one is designed to bind a single antigen with high precision, and that binding helps the immune system attack the target.
- ✓ III The monoclonal antibody m102.4 was procured by ICMR for Nipah cases, and a facility to administer it was set up in Kerala during the 2019 outbreak.
- • Since then WHO's fact sheet says there is no licensed specific treatment or vaccine for Nipah yet, so such antibodies are used on an emergency or experimental basis.
Remember · Monoclonal antibodies are lab-made, single-target antibody proteins; m102.4 is the one kept ready by ICMR against Nipah virus.
Sources
- A Comprehensive Review of Monoclonal Antibodies in Modern Medicine (NIH/PMC) ↗ “Monoclonal antibodies (mAbs) are laboratory-produced molecules engineered to mimic the immune system's ability to fight off harmful pathogens and diseased cells”
- Experiential learnings from the Nipah virus outbreaks in Kerala (ICMR authors, Indian J Med Res, via PMC) ↗ “monoclonal antibodies (m102.4) preparations and administrations in Nipah cases, if necessary.”
- WHO fact sheet: Nipah virus ↗ “There is currently no treatment or vaccine available for Nipah virus, however several candidate products are under development.”
Question and answer: UPSC's official GS Paper I (2025, Series A) — paper ↗ · answer key ↗. Explanation: Minimalist IAS, checked 30 Sept 2026 (how we verify). Permalink ·